ImmunoGen Inc IMGN dipped 23.12% to $6.45 in the pre-market session. IMGN has received a Refuse to File (RTF) letter from the FDA for its breast cancer treatment.
OmniVision Technologies Inc OVTI lost 2.85% to $21.50 in the pre-market session. OVTI had reported weaker-than-expected Q1 revenue.
Novell Inc NOVL fell 2.30% to $5.51 in the pre-market session. NOVL had posted weaker-than-expected FQ3 results.
ARM Holdings Plc ARMH slipped 0.91% to $15.29 in pre-market trading. ARMH’s earnings are likely to fall by 8.26% this year.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in